减肥药概念股银诺医药-B(2591.HK)已于今日中午截飞。据悉，银诺医药的公开发售部分录得超额认购约5364倍，超越了今年3月初挂牌的蜜雪集团(2097.HK)(超购5257倍)，成为今年超购王第二名；认购额涉资约3700亿港元。据悉，银诺医药吸引约26万人入飞。 银诺医药招股价为18.68港元，集资6.83亿港元。该股预计周五(15日)挂牌。中信证券、中金公司为保荐人。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.